Posts Tagged unknown-domain

Medicare Dx Payment System Will Be Market-Based, More Transparent Under New Law

Tuesday, April 8th, 2014 | Permalink

A new law makes vast changes to how clinical laboratory tests will be reimbursed by Medicare over the long term. Although the changes ultimately may lead to payment reductions, both test kits makers and laboratories applaud the new provisions. Reimbursement will better reflect the value that lab tests bring to the health care system, they say.

Link:
Medicare Dx Payment System Will Be Market-Based, More Transparent Under New Law

Device Firms See No Correlation Between Series A And Exit

Wednesday, March 26th, 2014 | Permalink

Large or small, Series A rounds in the device sector don’t have a statistical correlation with exit value, but there is some evidence that initial runway has some influence.

Read More:
Device Firms See No Correlation Between Series A And Exit

SYMPLICITY Results Make Life Difficult For Renal Denervation Programs

Wednesday, March 26th, 2014 | Permalink

The big slice of the device industry, from large-cap firms to venture capitalists, with some stake in the renal denervation opportunity are trying to understand the new reality now that Medtronic’s pivotal Symplicity renal denervation device trial missed its endpoint.

See the original article here:
SYMPLICITY Results Make Life Difficult For Renal Denervation Programs

Contact Us

Click or drag a file to this area to upload.